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Abstract 
Background 
In the search to optimize care of type II diabetics, computers have 
become an integral part of patient care. Clinical information systems are 
computerized systems that are increasingly being used in the medical field. 
Objective 
To examine the effectiveness of computerized clinical information 
systems on improving both physician management processes and patient 
outcomes in the management of type II DM compared to usual care with no 
system. 
Research Design and Methods 
This is a systematic review of Randomized Controlled Trials (RCT), 
Clinical Controlled Trials (CCT), and Controlled Before and After Studies (CBA) 
evaluating the effectiveness of clinical information systems used by health 
professionals in optimizing care for type II diabetics. The MEDLINE database 
(1994-2004) was searched using keywords: "type II diabetes" and "primary 
care," "community care," or "outpatient care." All articles that contained 
studies involving interventions in outpatient settings, directed at providers, and 
involving one component of computerized clinical information systems 
(diabetes registry, point-of-care reminder, feedback) were included in the 
review. 
Results 
A total of 6 studies met the inclusion criteria. Studies were RCTs, CCTs, 
or CBAs. All studies involved diabetes registries, 5 included physician feedback, 
and two involved computerized reminders. The quality of the studies ranged 
from good to poor, with only one study receiving a poor quality assessment. 
The clinical information systems showed marked improvement in the process 
of care for diabetic patients by providers. Yet, there was much less of a positive 
effect on actual patient outcomes. 
Conclusions 
Professional interventions that include clinical information systems will 
improve the process of care for diabetic patients. The effect of clinical 
information systems on patient outcomes is minimal. Longer studies in the 
future may reveal better patient outcomes as well as prolonged provider 
adherence to protocols. 
I 
Background 
Due to increased usage of computers in outpatient medical settings, this 
review is intended to update the findings on the effect of clinical information 
systems on physician adherence to guideline recommendations and intermediate 
outcomes of type II diabetic patients. 
Prevalence 
Type II diabetes, considered a disease of adults, accounts for 90-95% of all 
diagnosed cases. The age group most affected by this disease is those who are 60 
years and older. Eighteen point three percent of this population has diabetes (I). 
The current rates do not tell of the rapid increase in the prevalence of diabetes. 
As seen in a recent study, the prevalence of self reported diabetes has increased 
49% in the 10 years between 1990 and 2000. The prevalence increased from 
4.9% to 7.4% within the span of a decade. As of2000 the population of diabetics 
18 or older was estimated at 17 million people (5). With current rates the Census 
Bureau projects the population of diagnosed diabetics to reach 14.5 million by 
20 I 0 (8). The leading factor in the increasing prevalence of diabetes is the 1.3 
million cases of newly diagnosed diabetes each year ( 5). 
Impact on morbidity and mortality 
In the year 2000, diabetes was listed as the sixth leading cause of death in the 
United States. Because of the many complications of diabetes, it is likely that the 
disease has been underreported as the cause of death. (I) The cardiovascular 
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complications of diabetes may be mistaken as the primary cause of death 
in those who are never diagnosed as having diabetes. 
Due to the increased risk for atherosclerosis, diabetics have high rates of 
cardiovascular complications. (7) Some studies estimate the risk for 
cardiovascular disease between two and fourfold that of the general population 
(9). The resulting heart disease is the leading cause of diabetes-related death (1 ). 
Hypertension, retinopathy, nephropathy, and neuropathy are some intermediate 
outcomes that physicians monitor for. The incidence of blindness in diabetics is 
25 times that ofthe rest of the population (11). Some 35% new cases of end-stage 
renal disease are due to diabetic nephropathy. The resulting neuropathy 
contributes to 50% of non-traumatic lower extremity amputations (9). 
Economic costs 
Due to the increasing incidence of diabetes, the increase in diabetic 
medications, and resulting increase in lifespan, diabetes has become a major 
burden on the U.S. economy. In 2002 alone, an estimated $132 billion was 
attributable to both medical care and lost productivity. A total of $92 billion 
carne from direct medical expenditures. The lost work time, disability, and 
premature deaths associated with diabetes cost the U.S. $40 billion. Projections 
from the Census estimate the total cost of diabetes to rise to $156 by 2010. (6) 
Current Protocol for management 
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The 
American 
Diabetic 
Associatio 
nhas 
several 
goals that 
are not 
evidence 
based but 
have been 
formulated 
by expert opinion to set a level of diabetes control for physicians to try to reach. 
The ADA goal for control of glycemia is HbAI C level less than 7% which is 1% 
above the upper limits of normal (12). Although this goal has not been proven by 
evidence based medicine, both the Diabetes Control and Complications Trial 
(DCCT) and the U.K. Prospective Diabetes Study (UKPDS) found that 
maintaining HbA1 C levels -7% reduces the risk for microvascular complications. 
The trials also indicate that a 1 percentage point reduction at any HbA 1 C will 
reduce the risk for microvascular complications by 25% to 30% (25, 26), 
The current ADA goal for blood pressure control is systolic blood pressure 
less than 130 mm Hg and diastolic blood pressure less than 80 mm Hg. Clinical 
trials do indicate that a 1 Omm Hg reduction in blood pressure can lead to a 
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decrease in mortality rate of 35%, as well as a decreased risk of micro- and 
macrovascular complications (27). 
The goal for lipid management is as follows: lowering low density 
lipoprotein cholesterol (LDL-C) to less than l 00 mg/dL, increasing high density 
lipoprotein cholesterol (HDL-C) to greater than 45 mg/dL for men and 55 mg/dL 
for women and lowering triglyceride levels to less than 150 mg/dL. The National 
Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP-III) 
additionally sets a goal for total cholesterol levels of less than 200 mg/dL (8). 
The most recent study measuring the adherence to ADA and NCEP-ATP-III 
guidelines by diabetic patients is the National Health and Nutrition Examination 
Survey of 1999-2000 (NHANES 1999-2000) revealed tbat only 37% of diabetics 
have reached the HbA 1 C goal of <7%. More importantly the NHANES III 
revealed that around 24.9% of diabetics have HbAlC levels >9%. In tbe fight for 
blood pressure control, more than 113 of diabetics had systolic hypertension 
defined as SBP > 140 mm Hg; only 6.5% had diastolic hypertension >90 mm Hg. 
More tban 23% of diabetic patients failed to reach total cholesterol goals ofless 
tban 160 mg/dL( 4.2 mmolll) despite receiving preventive care (28) . Overall, a 
lowly 7.3% of adults with diabetes attained all three recommended goals. The 
NHANES 1999-2000 study showed no significant change in tbe amount of 
patients attaining targets ofHbAlC or blood pressure control, yet did show a 
significant decrease in tbe amount of patients with hypercholesterolemia (8). 
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for disease 
management for 
patients with type II 
.· 
-On_ce_ -a ~e-ar.-- DM. The American 
Diabetic 
Association has laid 
out a protocol that 
is less stringent yet 
outlines the minimal care to satisfY adequate diabetic monitoring. Strict 
adherence to the guidelines has promoted excellent outcomes in glycemic, blood 
pressure, and cholesterol control (1 0). Yet despite well known benefits of 
following guidelines, underuse of recommended preventive care practices is 
common (9). 
Chronic Care Model 
In order to optimize care for diabetes as well as other chronic illnesses, 
Bodenheimer, et a!. has created the chronic care model. This model included 4 
components: Self-management support, delivery system design, decision support, 
and clinical information systems. Self-management support involves helping 
patients and their supports acquire the skills and confidence to manage their 
chronic illness, providing self management tools, and routinely assessing 
problems and accomplishments. Delivery system design creates more efficient 
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practice teams with a delegation of labor to separate acute care from the 
planned management of chronic conditions. The physician deals with acute 
problems while non-physician personnel can support patient self-management and 
arrange routine testing, and examinations. Decision support involves using 
evidence-based clinical practice guidelines. These guidelines are then integrated 
into daily practice through reminders. The model also promotes more 
communication between generalists and specialists without official referrals. 
Clinical information systems are rooted in computer technology. Computers are 
used for 3 primary functions: 
b 
1) reminder systems to help physicians adhere to guidelines f 
2) feedback on physician performance on measuring chronic illness outcomes 
3) disease-specific registries that allow all data relating to the condition to go 
into an individual patient's registry file (13). 
Computerized Clinical Information Systems 
Medicine is one of the last leading industries to integrate computers into l T 
practice, yet many in the healthcare industry feel that computers are needed to 
optimize care of chronic diseases such as diabetes. Two previous systematic 
reviews include the examination of the effects of computerized reminders on 
improving management of type II DM in outpatient care (23) and (13). Renders 
found that computerized reminders both alone and in combination with other 
interventions improved process measures, yet had conflicting results in patient 
outcomes. Bodenheimer et. AI. used the Renders systematic review as a template 
to perform their own review on the process measures and patient outcomes of 
' L 
L 7 
interventions that were part of the chronic care model. The results 
suggested that clinical information systems both alone and in conjunction with 
other components of the chronic care modelled to both positive outcomes and 
positive processes. 
Objective 
To examine the effectiveness of computerized clinical information systems 
on improving both physician management processes and patient outcomes in the 
management of type II DM compared to usual care with no system. 
Research Design and Methods 
Identification of studies 
This systematic review included studies of diabetic care programs featuring the 
clinical information system component of Wagner, et. al. (24) chronic care model. 
Bodenheimer et. AI performed a similar search that included all components of 
the model ending in 2000. It was based on Render's et. AI systematic review 
under the effective Practice and Organization of Care (EPOC) review group 
search strategy. The EPOC review group is part of the Cochrane Collaboration 
which is an international organization that performs systematic reviews of the 
effects of health care interventions. The same search strategy from Render's 
study was used in this systematic review. The MEDLINE (1994-2004) database 
was searched using free-text words and key words regarding "type II diabetes" 
and "primary care," "community care," or "outpatient care." The search results 
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were limited to the English language due to lack of financial resources to 
translate any non-English publications. This produced 522 results. 
Study Selection 
Studies from the search results were included in the review if they evaluated 
the effectiveness of computerized clinical information systems directed at health 
care professionals who care for ambulatory patients with type 2 diabetes in 
primary care, outpatient, or community settings. Using modifications to the 
Cochran Effective Practice and Organization of Care Review Group (EPOC) 
inclusion criteria (Renders, 2001) the included studies had to be of one of the 
following designs: 
1) Randomized Controlled Trial (RCT): a train in which the participants (or other 
units) were definitely assigned prospectively to one or two (or more) alternative 
forms ofhealthcare using a process of random allocation (e.g. random number 
generation, coin flips). 
2) Controlled Clinical Trial (CCT): may be a trial in which participants (or other 
units) were: 
a) definitely assigned prospectively to one or two (or more) alternative forms 
of health care using a quasi-random allocation method (e.g. alternation, date 
of birth, patient identifier) or; 
b) possibly assigned prospectively to one or two (or more) alternative forms 
of health care using a process of random or quasi-random allocation. 
3) Controlled Before and After Study (CBA): involvement of intervention and 
control groups other than by random process, and inclusion of a baseline period of 
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assessment of main outcomes. There are two minimum criteria for inclusion 
of CBAs in EPOC reviews: 
a) Contemporaneous data collection 
Pre and post intervention periods for study and control sites must be the 
same. 
b) Appropriate choice of control site 
Study and control sites must be comparable with respect to level of care, 
setting of care, and academic status. L 
4) Interrupted Time Series (ITS): change in trend attributable to the intervention. 
There are two minimum criteria for inclusion ofiTS designs in EPOC reviews. 
a) Clearly defined point in time when the intervention occurred. 
The precise point in time of the intervention must be reported 
b) At least three data points before and three after the intervention. 
After ensuring that the article fit one of the previous study designs, the article 
had to fit the other inclusion criteria: 
1) The intervention had to be in an outpatient setting, including but not 
limited to hospital based ambulatory care clinics or private practices. 
2) This review is intended to study the effectiveness clinical information 
systems used by health care providers in optimizing care for type II 
diabetes. Therefore, studies that were only patient-oriented were excluded 
from the review. 1 
3) The intervention had to involve one component of clinical information 
systems: 
a. Computerized Diabetes Registry 
i 
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b. Computerized Point-of- Care Reminder 
c. Computerized Feedback system to reminder 
Articles included in the study also had to have an objective measurement of 
performance/provider behavior of health/patient outcome(s) in a clinical, not test, 
situation. 
The inclusion criteria were applied to each article in a stepwise fashion 
during the abstract review. If an inclusion criterion was applicable to an abstract 
or could not be determined from the abstract, the next inclusion criterion was 
applied. This process was repeated until an article was either stricken from the 
review or all inclusion criteria were met. Ifthere were still some question ofthe 
fit in the inclusion criteria at the end of the abstract review, the original article 
was examined to see if all inclusion criteria were met. 
Data Extraction 
Data extraction was performed by a single reviewer (E.B.) using an adapted 
version of the EPOC Data Collection Checklist (Appendix 1) (Cochrane EPOC, 
2002). A second reviewer was not used due to both finance and time constraints. 
If finances and time allowed, a second reviewer would be incorporated into the 
review to independently extract the data. A third reviewer would be called upon 
if there was any disagreement between the primary and secondary reviewer. 
Quality Criteria 
The quality of eligible trials was assessed using the standard criteria 
described by the EPOC group (Cochrane EPOC, 2002) The following seven 
11 L 
standard criteria were used for the randomized controlled trials (RCTs) 
and controlled clinical trials (CCTs), which made up the bulk of the studies 
reviewed: a) concealment of allocation (protection against selection bias); b) L 
follow-up of professionals (protection against exclusion bias); c) follow-up of 
patients or episodes of care; d) blinded assessment of primary outcome(s); e) 
baseline measurement comparability; f) reliability of primary outcome 
measure(s); g) protection ofthe control group against contamination. 
Since this study was based on provider specific interventions, concealment of 
allocation was scored DONE if the unit of allocation was by institution, team or 
professional and the authors described the method of randomization such as a coin 
toss or a computerized randomization. Concealment was scored NOT CLEAR if 
there was no explicit mention of the unit of allocation or method of 
randomization. Concealment was scored NOT DONE if the authors reported 
using alternation such as reference to case record numbers, hour of day seen, day 
of the week or any other such approach (as in CCTs); or the allocation was altered 
(by investigators, professionals, or patients) in a process such as matching. i .f:-t-
; 
Follow-up of professionals was scored DONE if greater than 80% of the 
professionals in the study had recorded outcome measures. If the follow-up rate 
was not specified in the paper the article received a NOT CLEAR. If outcome 
measures were obtained for less than 80% of the provider participants in the study 
the article received a NOT DONE. 
In order to further ensure quality of the study follow-rates of the patients 
within the study should also be high. Patient follow-up was scored DONE if 
patient outcome measures represented greater than 80% of the patients entered in 
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the study. The study received a NOT CLEAR if the follow-up rate was not 
specified in the paper. A score of NOT DONE was reserved for studies that 
stated a follow up rate less than 80%. L 
The primary outcome(s) were defined as those outcomes related to the 
authors' primary hypothesis. Assessment of the outcomes had to be blinded to 
prevent detection bias. Blinded assessment was scored DONE if the study stated 
that the primary outcome variables were assessed blindly or they were objective 
measures, e.g. HbAl C levels. A score of NOT CLEAR was given if quality of 
assessment was not specified in the paper. A score of NOT DONE was given in 
the outcome( s) were not blindly assessed. r 
A quality baseline measurement insures not confounding variables were 
present across study groups. Quality baseline measurement was scored DONE of 
the provider process measures ore patient outcomes were measured before the 
intervention and there was no considerable difference between the study and 
control groups. A study was given a score of NOT CLEAR if there is no report of 
baseline measures or it is unclear if there is a significant difference in baseline 
measures across the study groups. A score ofNOT DONE was recorded if there 
are differences in baseline measures that remain after the intervention. 
A study was given a score of DONE if the two or more raters of primary 
outcomes had a kappa greater or equal to 0.8. The score of DONE could also be 
given if the outcome came from an automated system, e.g. mechanized 
assessment of blood pressure. The score of NOT CLEAR was assigned to any 
paper in which reliability is not recorded in a paper that used chart extraction or 
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data collected by an individual. A score of NOT DONE was given to any 
studies with an inter-rater reliability ofless than 0.8. 
To protect against cross-contamination of study participants must remain 
separated by study arms. This is scored as DONE if allocation was done by 
practice, community, or groups within a practice and it is unlikely that the control 
population received the intervention. A score of NOT CLEAR was assigned if 
providers were allocated within a practice and it is possible that communication 
between the subjects could have occurred. A score ofNOT DONE is assigned to 
any study in which the control group received the intervention. 
Controlled before and after (CBA) designs followed slightly different quality 
criteria. The seven criteria were for a) baseline measurement; b) characteristic for 
studies using a second site as control; c) blinded assessment of primary 
outcome( s ); d) protection against contamination; e) reliable primary outcome 
measures; f) follow-up of professionals; and g) follow-up of patients. All scoring 
for the CBAs was the same as those ofRCTs and CCTs except scoring criteria b). 
If the characteristics of the study and control providers are similar, then a score of 
DONE is assigned. If the paper does not clearly have a table showing the 
similarities between providers, but the text does, a score of NOT CLEAR is 
assigned. A score ofNOT DONE is given if there is no report of characteristics 
in the text or table, or the table shows significant differences between the study 
and control providers. 
In order to give an overall grade for the quality of the paper, I created my 
own grading standard. Those studies that met six to seven criteria categories were 
given a grade of GOOD. Those studies that met four to five out of seven 
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categories were given a grade ofF AIR. Those studies that completed 3 or less 
criteria were given a grade of POOR. 
Data was extracted that contained either process measures of physician 
performance or patient outcomes as a result of diabetic care. Performance 
measures include, but are not limited, to percentage of patients with hemoglobin 
Al C (HbAl C) and low density lipoprotein-C (LDL-C) tests, a foot exam, and 
eye-exam by an eye care specialists in the previous 12 months. Patient outcome 
measures include, but are not limited to, mean HBAl C, LDL-C, and blood 
pressure levels. 
Data Analysis 
Data from included studies were tabulated in terms of means with standard 
error (SE) for patient outcomes and proportions for process measures, when 
possible; other data were presented as outlined in the original source. Data from 
each study were divided into diabetes care processes and patient outcomes when 
applicable. Baseline data were recorded to provide a comparable measure of the 
study groups. P-values tested the differences between the intervention and control 
groups in change in means or proportions from the baseline values. A statistically 
significant change was valued at P<O.OS. 
Due to the heterogeneity of interventions, study populations, settings, and 
reported outcomes, a pooled analysis was not possible. However a qualitative 
assessment of the effects of the studies was made based on the quality of the study 
and the magnitude and direction of the observed effects. 
t 
t 
L 
! 
t 
' +-
15 
Results 
The initial search strategy for articles yielded 530 results. Twenty-nine 
articles were removed for not addressing Type II Diabetes Mellitus. Another 355 
articles were eliminated for not being an RCT, CCT, CBA, or ITS. Three articles 
were removed for not being in an outpatient setting. One hundred one studies 
were removed for not being a provider focused intervention. Another 31 studies 
were removed for not encompassing one of the components of clinical 
information systems. This left 11 studies available for article review. Due to time 
and financial constraints, any articles which could not be found either online or 
through the University ofNorth Carolina Health Sciences Library were also 
eliminated; this number included 3 more studies. After further examination, two 
more studies were removed from the review, one for being in French and the 
other for being a planned study. This elimination scheme left 6 studies that met 
the inclusion criteria of this review. A flow diagram has been provided in (figure 
1). 
A rather equal distribution of study types were represented in the included 
studies. Two of the six studies were EPOC Criteria approved randomized 
controlled trials; two were clinical controlled trials; and 2 were controlled before 
and after studies. 
In 5 of the 6 studies (15-19,) the interventions and process measurements 
were based on clinical guidelines for the management of type II diabetes. One 
study (19) was based on the American Diabetic Association guidelines for 
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management ofhyperglyceridemia, hypertension, and hyperlipidemia; two 
(15, 16) were base on national guidelines, one (16) was based on local guidelines, 
and one study (18) did not record the source of the guidelines. 
Computerized reminders were the intervention in 2 studies (17, 20). Often it 
was in combination with the other two clinical information systems components. 
Based on the results computerized reminders seem to have a positive effect on 
physician process measures related to type II DM care, and a positive effect on 
patient outcomes. 
Physician feedback was the primary intervention in five out of six studies 
(15-19). Although this was also found in combination with the other components 
of clinical information systems, it was never the sole intervention any study. 
Based on the results physician feedback seems to have a positive effect on 
physician process measures related to type II DM care, and a positive effect on 
patient outcomes. 
Registries were included in the intervention in veritably all of the studies (15-
20). Oftentimes registries were used in conjunction with specialist and other 
health care professional communication with the primary care providers. Based 
on the results diabetic patient registries seem to have a positive effect on 
physician process measures related to type II DM care, and a positive effect on 
patient outcomes. However, the broad use of a combination of the components of 
clinical information systems makes positive outcomes and process measures 
attributable to a specific component difficult. 
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Meigs, et. al. 2003 
Meigs et. a!. performed a randomized controlled trial examining both patient 
outcomes and diabetes management after application of a web-based information 
management/clinical decision support tool, which included both patient -specific 
registries and feedback base on national guidelines for diabetes, hyperlipidemia, 
and hypertension. No involuntary reminders were included in this study. Based 
on EPOC quality criteria, this study was performed in an adequate manner. 
However, a score of NOT DONE was given to the baseline measurement because 
there was a significant difference in the amount of foot examinations per year 
between the study and control groups at both baseline and in change from 
baseline. Even though the physicians included in the study remained throughout 
the entire study period, they only used the diabetes management application 
(DMA) during 42% of scheduled visits. The authors did note that a secondary 
"treatment received" analysis did produce similar effects as the intention-to-treat 
analysis, which underlines the effectiveness of the DMA. The Meigs study 
received an overall quality rating of GOOD with 6 out of7 quality criteria met. 
In regards to patient outcomes as the result of the DMA, the system showed 
only a negative effect on mean systolic blood pressure levels. All other patient 
outcomes were nonsignificant. There was no significant change in patient 
proportions reaching guideline recommended levels ofHbAlC<7%, LDL-C 
<130mg/dl, or blood pressure <130/85 as compared with the control group. There 
was also no significant change in mean HbAlC, mean LDL-C, and mean diastolic 
L 
i 
L 
F 
18 
blood pressure. The glycemic control did show an increase in the intervention 
group and decrease in the control group. 
Process measures improved with the intervention. There was a significant 
improvement in the mean number ofHbA1C tests per year, the mean number of 
LDL-C tests per year, and the percentage of patients receiving at least one foot 
examination in the past 12 months. In the measure of patients receiving a foot 
examination, 82% of the control group and 65.5% of the intervention group 
received one in the past 12 months at baseline. The significant change in the 
intervention group is likely attributable to the upper threshold of care of the 
control group. 
Grant, et.al. 2003 
Grant, et. al. performed a controlled before and after study examining the 
effects of population based feedback on the processes of care for type II diabetics. 
One hundred forty-nine patients with the highest HbA1 C and cholesterol levels at 
one primary care sight were selected for intervention of e-mail recommendations 
based on ADA guidelines to the patients' PCP. Another site, matched in a 1: 1 
ratio within 5 years of age, 0.5% HbA1 C, and 10 mg/dl total cholesterol, served 
as the control group. 
Because Grant, et. al. performed a controlled before and after study, selection 
bias is inherent in the fact that the investigators chose the control population. 
However, matching by the patient outcomes of interest may have decreased some 
of the bias. Baseline characteristics of the patient populations were DONE in a 
proper fashion. There were no significant differences between intervention and 
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control patient populations. Baseline measurement of providers showed that 
there were substantial differences across the study groups. Physicians at the 
intervention site had significantly less amount of training, 12.9 years (SD 7.0), 
than those of the control site, 22.9 years (SD 10.0), p-value <0.0001. They also 
performed less cholesterol checks in the previous year per patient 1.1 (SD 0.9) vs. 
1.3 (SD 1.0), respectively, p-value = 0.04. Because the results of tests and testing 
rates were recorded on an electronic medical record (EMR,) there was adequate 
protection against selection bias and reliable measurement of primary outcomes. 
Due to the fact the control site was a completely separate practice, there was no 
potential for contamination. Follow up of professionals was adequate, but follow 
up of patients was not properly performed. Only 74% ofthe patients were seen 
during the 3-month follow up period. Grant received an overall quality rating of 
t 
I FAIR with 5 out of 7 quality criteria being met. 
Recommendations made by the population manager to the physicians 
were either for repeat testing (ofHbA1C, blood pressure, or cholesterol), or 
change in therapy (for glycemic, blood pressure, or cholesterol control.) There 
was a significant difference in percentage oftotal recommendations followed 
between intervention (59%) and control sites (45%), (p = 0.2). However there 
was no significant difference in percentage of recommendations when the 
recommendations were analyzed by repeat testing or changes in therapy. These 
results show that there is a significant change in adherence to evidence-based 
guidelines with the implementation of population based feedback. However due 
to the rather short follow-up period of 3 months, this study does not tell if 
adherence is maintained throughout the care of such a chronic disease. 
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Olivarius, et. al., 2003 
Olivarius, et. a!. performed a randomized controlled trial involving regular 
follow-up and individualized goal setting of patients supported by prompting of 
doctors, clinical guidelines, feedback, and continuing medical education in the 
treatment of type II diabetes. Therefore, actual use of clinical information 
systems is but a small part of this intervention. This large study included 311 
practices and 474 providers in Denmark in a study that lasted 48 months. 
This study was strongly performed by EPOC quality standards. Allocation 
was adequately concealed by stratification and then randomization by random 
numbers into two groups. Only 10 (2%) of the 484 practitioners who volunteered 
dropped out of the trial after randomization, thus protecting against any exclusion 
bias. Yet, outcomes were not attained for 31% of patients that met the study's 
inclusion criteria. A great majority (23%) of those patients died before 
completion of the intervention; the others died before the completion of follow-up 
(2%), withdrew consent (3%), or was lost to follow-up (3%). Detection bias for 
the outcome was prevented by using computerized assays. The only in which 
reliability was not clear was for retinopathy. A separate group of 
ophthalmologists performed the eye exam and there is no recording of inter-rater 
reliability. At baseline there were no significant differences across study groups 
for process measures or patient outcomes. Because the clinicians were 
randomized by practice it is unlikely that there was any contamination in the 
study. With 6 out of 7 quality criteria met, Olivarius received an overall quality 
rating of GOOD. 
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The multi-faceted intervention had a positive overall effect on outcome. 
The intermediary marker levels of median fasting plasma glucose (7.9mrnll vs. 
8.7mrnll, p = 0.0007); median HbA1C% (8.5 vs. 9.0, p<0.0001); and percent of 
patients with glycosuria (22 vs. 37, p<0.0001) were all significantly improved by 
the intervention. There was no substantial effect on mean total cholesterol levels, 
fasting triglyceride levels, or serum creatinine levels. There were significantly 
less patients with albuminuria> 15mg/l (22.5% vs. 30.8%, p = 0.04). There were 
no significant decreases in the major endpoints of diabetes with respect to overall 
mortality, diabetic retinopathy, myocardial infarction, stroke, peripheral 
neuropathy, or amputation at the p <0.05 level. 
The intervention tested by Olivarius et. al. also showed improvement in 
process measures. Due to the intense management at the primary care site, less 
patients had to be referred to a diabetes clinic (17% vs. 26%, p=0.009). There 
was also an increase in the median amount of diabetic related consultations per 
year for each patient ( 4 (interquartile range 3-6) vs. 4 (interquartile range 2-6), 
p<0.0001). The number ofhospital admissions was the same in each group. 
Vaughan and Potts, 1996 
Vaughan and Potts performed a clinical controlled trial involving a decision 
support system with reminders that can be applied to a computer. Reminders are 
based upon hyperglycemia treatment methods, the patient's current state of 
glycemic control, trend of glycemic control, current BMI, and weight changes. 
This trial tests if such an intervention will improve diabetic control if used by a 
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primary care nurse. General practices within the United Kingdom were 
divided into an intervention and control group, matching for size, geographical 
area, and standards of existing diabetes care. 
This article achieved 3 out of 7 of the EPOC quality criteria for a clinical 
controlled trial, which made it a POOR study. Because the study did not have a 
randomization scheme protection against selection bias was not strong. There 
was no mention offollow-up rates of the professionals involved in the study. The 
article also failed to mention how the study was narrowed to 228 total patients. 
Although it did mention some exclusion criteria, the study failed to mention 
patients who dropped out or were lost to follow-up. Because all HbA1 C 
measurements are objective values protection against detection bias can be 
maintained, and the primary outcome of HbA 1 C level is reliable. Baseline 
measurements and comparisons between study and control groups did state 
similar weights and treatment regimen, yet failed to compare baseline HbA 1 C 
levels. Because all control patients were seen at clinics other than the intervention 
clinic, contamination is unlikely. Beyond EPOC Criteria, the Vaughan study was 
poorly written. Without a baseline measure ofHbA1C values for each of the 
groups, it is impossible to follow the data that they claim. Also, values given in 
the results section of the test do not correspond to the results given in the data 
table. Because the ruleset study excluded patient with serious coexisting diseases 
such as cardiac and renal failure, the ruleset itself cannot be applied to these 
patients. 
Despite its many limitations, the Vaughan study found that the intervention 
led to an increased proportion of patients with HbA1C values <7.5% (88% vs. 
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63%, p<O.OS). Although a process measure was performed in the study, a 
lack of statistical significance measure excludes it from being reported in this 
review. 
de Sonnaville, et. al., 1997 
de Sonnaville, et. al. performed a clinical controlled trial examining the 
effects of a structured care program for type II diabetics that involved a laboratory 
with facilities to visit patients at home, a computerized patient register and recall 
system, a wide-angle retinal camera, a dietician, diabetes nurse educator, a 
podiatrist, and a diabetologist available 24 hours per day. The study group 
contained 22 general practitioners, while the control group contained six. These 
two groups were not matched for any characteristics. 
This study was fairly performed by EPOC standards. Five out of seven 
EPOC quality criteria were reached in the study, which made it FAIR. The lack 
of either randomization or matching greatly decreases the strength of the study. It 
is not know whether one group of physicians had greater experience dealing with 
diabetic patients, and therefore having a patient population that had better 
glycemic control. All 28 professionals did participate in the follow-up to the 
intervention. The study failed at assuring optimal follow-up of the study and 
control patients. Some 23 .I% of the intervention patients dropped out during the 
2 years of follow up. Another 33.3% of the control population dropped out during 
the follow up period. All outcomes were performed by computer assays, 
therefore detection bias was avoided. Baseline measurements of outcomes were 
performed, which yielded significantly more men, a higher fasting glucose and a 
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higher systolic blood pressure in the control group. Because the outcome 
measures were objective measures of diabetes, the primary outcome measures 
were deemed reliable. Contamination was avoided by allocating the intervention 
and control to different practices within Amsterdam. 
Sonnaville revealed a significant improvement in patient outcomes as the 
result of this intervention that included a computerized patient register and recall 
system. This system showed marked results in the area of glycemic control. 
Mean fasting plasma glucose of the intervention group was improved significantly 
over that of the control group. Fasting plasma glucose went from 8.9 ± 2.5 to 8.1 b 
± 2.5 mmol/1 in the study group while it went from 9.6± 3.4 to 9.8 ± 2.9 mmol/1 in f 
the control group (p=0.004). Mean HbA1C (%)produced similar findings when 
intervention went from 7.4 ± 1.6 to 7.0 ± 1.3% and control went from 7.4 to 7.6% 
(p=0.004). The percentage of patients with an HbA1 C <7.5% followed the same 
trend ofthe previous measures of glucose control with the proportion improving 
from 43.4 to 54.3% in the study group and regressing from 54.4 to 44.1% in the 
control group (p=0.008). The total cholesterol level changed in a similar fashion 
as the glucose control markers in that the intervention group improved while the 
study group progressively worsened, 6.1 ± 1.3 to 5.8 ± 1.1 and 5.9 ± 1.0 and 5.9 ± 
1.0 mmo1/l respectively (p=0.002). There was no significant improvement as a 
result of the intervention for all other diabetic outcomes. 
Branger, et. al., 1997 
Branger, et. al. performed the second controlled before and after study (1-year) in 
the review. This study examined the effects of an electronic communication 
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network combined with a patient registry and reminders on the patient 
L 
outcomes and the management of type II diabetes mellitus. The computerized 
system tested allows the physician to inspect and record clinical data during the 
patient encounter then reminds the physician to compose a message for 
communication with other providers for the patient. The 20 general practitioners 
who referred the highest number of patients to a diabetic consultant were selected 
to the intervention group, while the remaining 12 providers were allocated to the 
control group. The intervention providers were given the inter-physician 
communication module while the control physicians continued with their usual L 
care for patients. 
Branger' s study met 4 out of 7 quality criteria for EPOC reviews which made 
it a FAIR study. Proper baseline measurement was not done during this study. 
There were more type I diabetics in the control population (43%) than in the 
intervention (29% ). This creates a problem in trying to compare patient outcomes 
due to the risk of hypoglycemia in type I diabetics. Characteristics of the study 
and control providers were similar yet not clear due to a lack of data table 
comparing the providers in each group. Each group had an average of 12 contacts 
per patient per year in 1993 and 14 contacts per patient per year in 1994. Since 
the outcomes and process measures were taken from the electronic data 
interchange (EDI), there was adequate protection against detection bias. Since the 
EDI was only equipped in study practices, contamination of the study was highly 
unlikely. The automated system recording outcomes ensured reliability of the 
outcomes. There were no drop-outs for professionals or patients, thereby 
fulfilling the last two EPOC criteria. 
26 
Only one measure of patient outcomes was performed in this trial. 
HbAlC was not significantly changed as a result of the intervention. The 
baseline mean values for intervention and control were 7.0 and 6.6%, 
respectively. The mean difference after the follow-up period was -0.12 ± 0.36 
and -0.21 ± 0.19%, respectively, (p=0.68). 
Use of the intervention let do an increase in several process measure for 
diabetes. The amount of tests for kidney function was not significantly improved. 
This included both serum creatinine levels and proteinuria. There was no 
significant increase in ophthalmologist assessments either. Glucose control 
significantly improved as the result of the intervention. Both HbAl C and 
fructosamine level tests per patient per year increased at a significant level, 
p=0.003 and p=O.Ol, respectively. Checks for hypertension were also improved, 
p=O.OOO. Hyperlipidemia control became more important as well. Cholesterol 
and triglyceride assessments were also increased, p=0.03 and p=0.02, 
respectively. Due to the link between weight and glucose control, frequent 
analysis of weight is important. Weight checks were increased significantly due 
to the EDI, p=O.OOO. 
Discussion 
This review was performed to identify components of clinical information 
systems (CIS) that improved care for type II diabetics by either better control over 
outcomes or optimization of management. Although several studies exist that 
address clinical information systems and their use for diabetes-self management, 
this review focused on CIS that was created for provider use. In addition to 
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randomized controlled trials, studies with controlled before and after and 
clinical controlled trials that fulfilled the EPOC group methodolological and 
quality criteria, met the review's inclusion criteria, and were published between 
1994 and 2004 were included. A total of 6 studies were therefore included in this 
review. 
Electronic registries were used throughout each of the studies involved in the 
review. Because it is a constant throughout all interventions, this cannot be 
directly attributed to making an impact on diabetes care. However, without the 
use of diabetic registries within electronic medical records, the other two 
components of clinical information systems can not exist. Thus, I can conclude 
that the combination of patient specific registries combined with other aspects of 
clinical information systems improves both patient outcomes and the process of 
care. 
Computerized reminders were used in two of the six studies. One study 
received an overall quality rating of GOOD while the other received a rating of 
FAIR. These two studies found a positive effect on process measures through the 
use of computerized reminders combined with other interventions. Results 
suggest that the number of diabetes specific laboratory tests increase with the use 
of reminders. This improved care translates into optimization of primary care 
management of diabetes, which is suggested by a decrease in percentage of 
patients treated in a diabetes clinic each year. 
Feedback to physicians allows physicians to gauge their performance based 
on treatment goals. These treatment goals are usually outlined by evidence based 
guidelines for improving diabetes care (20). Five out of six studies incorporated 
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physician feedback into their intervention. The percentage of 
patients having good control (<7.0% HbAlC) seems to improve with the use of 
feedback on physician performance. Two studies showed a positive effect while 
one study showed no effect. Only one study addressed the effect of feedback on 
the other measures of good diabetic control (BP<l30/85mmHg and LDL-
C<l30mg/dl). It showed no significant effect on the percentage of patients 
reaching these goals. 
Feedback has been proven to positively affect process measures (21 ). 
Computerized feedback seems to have the same effect. One of the stronger 
studies showed an increased number ofHbAlC and LDL-C tests performed per 
patient per year. The same study also showed an increased likelihood of getting a 
foot examination. These early interventions have the potential of decreasing some 
endpoint outcomes of diabetes, yet there is no clearly defined relationship. 
Limitations of the review 
The fact that most of the studies included in the involved other interventions 
outside of the use of clinical information systems must be emphasized. Due to the 
multitude of additional interventions, any potential effect of clinical information 
systems on both diabetic outcomes and processes of care is diminished. In one 
study clinical information systems were used to support other main interventions 
such as population management (15). Improvement in outcomes cannot be 
attributed to computer information systems alone, yet they do play a significant 
part in optimizing patient care. 
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The small number of studies is another limitation to this review. This 
is due in large part to the time commitment of the study and lack of monetary 
resources. Oftentimes, two or more reviewers perform vast searches on multiple 
databases, because these projects are funded by federal grants and private 
organizations. With a lack of such financial resources, this systematic review was 
carried out on only one database, MEDLINE (1994-2004). Due to the progressive 
use of computers in outpatient medicine, some of the most recent research may 
not have been catalogued in MEDLlNE when the review was performed. The 
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lack of monetary resources also limited the ability to identify unpublished studies. 
The methodological quality of the included studies was often limited. 
Although there were two studies rated as good by the EPOC quality criteria, even 
these studies had their limitations. One study failed to ensure that there were no 
baseline differences that might alter the post-intervention statistics( IS). The other 
failed to ensure >80% follow up of the patients (17). The most common 
limitations to the individual studies included lack of concealment of allocation, 
lack of physician follow-up, patient follow-up and proper baseline measurements. 
Generalizability 
Due to fairly strict inclusion criteria of the individual studies, application of 
the results of this review can be applied only to the care of type II diabetic 
patients that have no other severe co-morbidities. The studies were also 
performed in various national and regional settings. Nations other than the United 
States have both different patient demographics and different health care systems. 
Because the non-white population is so small in Europe, being of this group was 
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often an exclusion criterion. Therefore, it is difficult to apply some results to 
the American Diaspora. The different health care systems create differences in 
training of physicians. If one nation already puts more emphasis on structured 
care for diabetes, the impact of CIS may be diminished. Thus, generalizations 
from this review should be done with some reservations. 
Implications for futnre research 
The results have shown that although CIS may not be sufficient to optimize 
care for type II diabetes, but it is necessary. The use of computer systems 
streamlines the delivery of care for complex diseases such as diabetes. It allows 
for better communication between professionals, which translate in more 
continuity of care. 
In this review only 3 out of the 6 studies recorded both patient outcomes and 
physician process measures. Patient outcomes have long been benchmarks for 
judging quality of care, yet the activity of physicians is also a good indicator. 
Without process measures, the implementation rate of needed interventions would 
be overlooked. Therefore, both process measures and patient outcomes should be 
incorporated in future research. 
Due to the rapid progression of computer technology, and the rapid pace of 
medical practice, physicians may find adjustment to new computer systems 
difficult. Qualitative assessments of physician level barriers to use of CIS should 
be included in future studies. The feedback from providers indicating the aspects 
of CIS that make practice easier and more difficult should assist in optimizing 
more user friendly systems. Because the physician-patient relationship is so 
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crucial to improved care for chronic diseases, qualitative research should 
also involve patients to assess any barriers CIS promotes between patient and 
provider. 
Longer research studies should be implemented to determine the long term 
effectiveness of the use of CIS when incorporated into structured care. The 
longest follow-up period in this review was only 4 years. A majority of the 
studies in this review addressed intermediary outcomes that are merely predictors 
of endpoint outcomes. A longer study that measures endpoint outcomes such as L 
overall mortality, myocardial infarctions, kidney failure, blindness, and 
amputations, will better judge the long term benefits of CIS. These longer 
research projects can also be used to determine if use of clinical information 
systems leads to prolonged adherence to guidelines by physicians. 
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Figure 1 
Initial Search Strategy: MEDLINE (1994-2004) searched using free-text and 
keywords "type II diabetes" and "primary care," "community care," or "outpatient 
care." Limits: English Language. 
Results: 530 articles 
I Article Addresses Type II DM. I 
YES NO 
501 Articles 29 Articles 
I Article is an RCT, CCT, CBA or ITS. I 
YES NO 
146 Articles 355 Articles 
Study is performed in an outpatient setting. 
YES NO 
143 Articles 3 Articles 
I Intervention is provider focused. I 
YES NO 
42 Articles 101 Articles 
I Intervention involves clinical information system component. I 
YES NO 
II Articles 31 Articles 
I Article found in UNC Health Sciences Library. I 
I 
YES NO 
8 Articles 3 Articles 
Article is written in the English Language. 
YES NO 
7 Articles I Article 
I Study has been completed. I 
YES NO 
6 Articles I Article 
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Author 
Year 
Sonnaville, 
1997 (18) 
Branger, 
1999 (19) 
a) Number 
of providers 
Intervention b) Number 
i) intervention of patients Follow-
group c) c) Number up 
Desi_9_!!_ contr()l g_r()~p _Qf_practices Setti119 _ (months) 
CCT i) computerized a) 28 Netherland 24 
CBA 
patient register b) 561 general 
and recall system c) unknown practice 
c) usual care 
i) computerized 
registry with 
electronic 
communications 
module 
c) paper based 
communication 
a) 32 
b) 275 
c) unknown 
Netherland 
general 
practice 
12 
Quality 
Criteria* 
a) NOT DONE 
b) DONE 
c) NOT DONE 
d) DONE 
e) DONE 
f) DONE 
g) DONE 
a) NOT DONE 
b) NOT 
CLEAR 
c) DONE 
d) DONE 
e) DONE 
f) DONE 
g) NOT DONE 
Results 
Patient outcomes Intervention Baseline/L\ Control Baseline/L\ 
(+)Mean FPG (mmoVI) 8.9(2.5)/-0.8 9.6(3.4)/+0.2 
(+)Mean HbA1C (%Hb) 7.4(1.6)/-0.4 7.4/ +0.2 
(-) BMI (kg/m2) 28.7(4.6)/ +0.3 26.8(4.0)/-0.3 
(+) HbA1C <7.0% 43.4%/ + 10.9% 54.4%/-10.3% 
(+) Tot Chol (mmoVI) 6.1 (1.3)/-0.3 5.9(1.0)/ 0.00 
(0) HDL Chol(mmol/1) 1.21(0.36)/-0.05 1.14(0.35)/-0.0 
(0) Triglycerides (mmol/1) 2.12(1.64)/-0.16 2.01 (1.46)/+0.02 
(0) Mean SBP (mmHg) 146.9(20.9)/ +0.8 155.4(24.0)/-0.1 
(0) Mean DBP (mmHg) 87.4(10.8)/-4.4 88.8(11.4)/-3.5 
p-value 
0.004 
0.004 
0.000 
0.013 
0.002 
0.40 
0.12 
0.70 
0.59 
Conclusion 
patient(+) 
study quality 
(FAIR) 
Patient outcomes Intervention Baseline/L\ ControiBaseline/L\ p-value patient (0) 
(0) Mean HbA1C(%Hb) 7.0/-0.21 6.6/-0.120 0.68 process(+) 
Process Measures Intervention Baseline/A Control Baseline/A p-value 
(0) Ave. CreatininepUyr 
(0) Ave. Proteinuria/pUyr 
(0) Ave. Optho. consulUpUyr 
(0) Glucose level/pUyr 
(+) HbA1C level/pUyr 
( +) Blood Pressure/pt/yr 
(+)Triglyceride level/pUyr 
( +) WeighUpUyr 
0.2/ +0.3 0.2/ +0.2 NS 
0.1/0.0 0.2/ +0.3 NS 
0.2/ 0.3 0.3/ +0.0 NS 
1.0/+0.9 1.6/+0.2 NS 
0.01 +0.8 0.0/ +0.2 0.003 
0.6/ +1.3 1.3/ +0.1 0.03 
0.01 +0.2 0.0/ +0.1 0.02 
0.2/ +1.8 0.2/ +0.3 0.000 
study quality 
(FAIR) 
*Quality Criteria is as follows: RCT/CCT a) consealment of allocation (protection against selection bias), b) follow-up of professionals (protection against 
exclusion bias), c) follow-up of patienst or episodes of care, d) blinded assessment of 1° outcome(s) (protection against detection bias), e) baseline 
measurement, f) reliable 1 o outcome measure(s), g) protection against contamination; CBA a) baseline measurement, b) characteristics for studies using 
second site as control, c) blinded assessment of pirmary outcome(s), d) protection against contamination, e) relieable primary outcome measure(s), f) follow-
up of professionals, g) follow-up of patients; t Baseline characteristic difference, p < 0.05; 
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Author 
Year 
Olivarius, 
2001 (16) 
a) Number 
of providers 
Intervention b) Number 
i) intervention of patients Follow-
group c) c) Number up 
Design control group of practices Setting (months) 
RCT i) regular follow- a) 474 Danish 48 
up and b) 874 general 
individualized c) 311 practices 
goal-setting 
supported by 
prompting of 
doctors, clinical 
guidelines, 
feedback, and 
CME 
c) doctors free to 
choose any tx 
Vaughan, CCT i) computerized 
decision support 
system with 
ruleset reminders 
based on pt. 
registry 
a) 1 
intervention 
nurse; 
several 
control 
nurses 
Primary 
care 
practice in 
UK 
Not 
stated 1996(17) 
c) conventional 
care 
b) 228 
c) NOT 
CLEAR 
Quality 
Criteria* 
a) DONE 
b) DONE 
c) NOT DONE 
d) DONE 
e) DONE 
n DONE 
except NOT 
CLEAR 
retinopathy 
g) DONE 
a) NOT DONE 
b) NOT 
CLEAR 
c) NOT 
CLEAR 
d) DONE 
e) NOT 
CLEAR 
n DONE 
g) DONE 
Results 
Patient outcomes Intervention 
(0) Overall mortality 216/649(33.3%) 
(0) Diabetic Retinopaythy 43/359(12.0%) 
(+)Albuminuria ~ 15mg/L 56/249(22.5%) 
(0) Myocardial Infarction 15/437(3.4%) 
(0) Stroke 18/446(4%) 
(0) Periph. Neuropathy 69/375(18.4%) 
(0) Angina Pectoris 22/371 (5.9%) 
(0) Amputation 2/459 (0.44%) 
Control 
208/614(33.9%) 
45/330(13.6%) 
72/234(30.8%) 
18/393(4.6%) 
16/405(4%) 
69/405(21 %) 
23/346(6.7%) 
4/414(0.97%) 
Patient outcomes Intervention Baseline/~ Control Baseline/~ 
(+)Median FPG (mmol/1) 13.8/-5.9 13.7/-5.0 
(+)MedianHbA1C(%Hb) 10.2/-1.7 10.2/-1.2 
(0) Med. Tot. chol (mmol) 6.2/-0.2 6.2/-0.1 
(0) Med. Triglyceride (mmol/1) 2.03/-0.25 1.98/-0.09 
(0) Med. Serum Creat(~moVI) 90/-1 88/ +3 
(+)Median SBP (mmHg) 150/-5 148/ +2/ 
(0) Median DBP (mmHg) 85/-5 85/-1 
Process Measures Intervention 
(+)No.(%) tx at diabetes clinic 79/459(17%) 
(+) Med. Diabetes consults/yr 4 (3-6) 
(0) No. of Hosp. Admits since dx 1 (0.3) 
Control 
1 06/415(26%) 
4 (2-6) 
1 (0-3) 
p-value 
0.82 
0.55 
0.04 
0.40 
0.95 
0.41 
0.68 
0.35 
p-value 
0.0007 
<0.0001 
0.12 
0.32 
0.84 
0.0004 
0.40 
p-value 
0.009 
<0.0001 
0.79 
Patient outcomes Intervention Control p-value 
(+)No. Pts with HbA1C <7.5% 90/102(88%) 73/116(63%) <0.005 
Conclusion 
patient(+) 
process(+) 
study quality 
(GOOD) 
patient(+) 
study quality 
(POOR) 
*Quality Criteria is as follows: RCT/CCT a) consealment of allocation (protection against selection bias), b) follow-up of professionals (protection against 
exclusion bias), c) follow-up of patienst or episodes of care, d) blinded assessment of 1 o outcome(s) (protection against detection bias), e) baseline 
measurement, f) reliable 1° outcome measure(s), g) protection against contamination; CBA a) baseline measurement, b) characteristics for studies using 
second site as control, c) blinded assessment of pirmary outcome(s), d) protection against contamination, e) relieable primary outcome measure(s), f) follow-
up of professionals, g) follow-up of patients; t Baseline characteristic difference, p < 0.05; 
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Table I. Intervention versus control 
Author 
Year 
Meigs, 
2003 (14) 
Grant, 
2003 (15) 
a) Number 
of providers 
Intervention b) Number 
i) intervention of patients Follow-
group c) c) Number up 
Design control group of p_r_~~t-~~~ _____ §_~il'lg (f!!onths,) 
RCT i) voluntary, web- a) 66 hospital- 12 
based feedback, b) 598 based 
individualized c) 1 staff-
patient registries resident 
c) standard practice 
practice 
CCT i) diabetes a) 59 academic 3 
registries, internists + affiliated 
recommendations 8 nurse community 
on via email practitioners health 
c) registries b) 298 center 
wlhypothetical c) 2 serving 
recommendation- working 
feedback class 
Quality 
Criteria* 
a) DONE 
b) DONE 
c) DONE 
d) DONE 
e) NOT DONE 
f) DONE 
(process); 
DONE 
(outcomes) 
g) DONE 
a) DONE 
b) NOT DONE 
c) DONE 
d) DONE 
e) DONE 
f) DONE 
g) NOT DONE 
Results 
Patient outcomes 
(0) HbA1C<7% 
Intervention Baseline/.1. Control Baseline/Ll 
21.7% I +1.7% 26.6%/-2.8% 
(0) Mean HbA1C (%Hb) 
(0) LDL-C <130mgldl 
8.41-0.23 8.11+0.14 
54.8% I +20.3% 63.5% I +1 0.5% 
(0) Mean LDL-C (mgldl) 
(0) BP <130185 mmHg 
(-)Mean SBP (mmHg) 
(0) Mean DBP (mmHg)t 
126.7(3.1) 1-14.7 122.1 (3.2) 1-9.4 
25.4% I +1.4% 29.6% I +2.2% 
138.1 (1.2) I +0.8 136.9(1.2) 1-2.2 
78.3(0.6) 1-1.8 76.4(0.6) 1-0.8 
Process Measures 
(0)1+HBA1Cpast12mo 86.0%1+1.6% 
(+)Mean# HbA1C testslyr 1.7(0.1) I +0.3 
(0)1+LDL-Cpast12mo 54.8%1+7.2% 
(+)Mean# LDL-C testslyr 0.8(0.1) I +0.2 
(0) 1+ BP past 12 mo 97.5% I +1.0% 
(0) 1 + eye past 12 mot 29.3% I +5.5% 
(+) 1+ foot past 12 mot 65.5% I +9.8% 
Process Measures Intervention 
(+)Tot. Rec, recfollow/recmade 961162(59%) 
(0) Rpt test, recfollowlrecmade 69188(78%) 
(0) A in tx, recfollow/recmade 27174(36%) 
88.0%/-1.0% 
1.8(0.1) 1-0.04 
57.4% I +3.4% 
0.9(0.1) I +0.01 
98.6%/-1.4% 
41.2%/+1.7% 
82.1%/-0.7% 
Control 
841186(45%) 
50172(71%) 
341114(30%) 
Repeat testing = for HBA 1 C, blood pressure, or cholesterol 
p-value 
0.2 
0.09 
0.5 
0.3 
0.8 
0.03 
0.8 
0.3 
0.008 
0.5 
0.02 
0.3 
0.5 
0.003 
p-value 
0.02 
0.4 
0.3 
Changes in thereapy =for glycemic, blood pressure, or cholesterol control 
Conclusion 
patient(-) 
process(+) 
study quality 
(GOOD) 
Process(+) 
study quality 
(FAIR) 
*Quality Criteria is as follows: RCT/CCT a) consealment of allocation (protection against selection bias), b) follow-up of professionals (protection against 
exclusion bias), c) follow-up of patienst or episodes of care, d) blinded assessment of 1' outcome(s) (protection against detection bias), e) baseline 
measurement, f) reliable 1' outcome measure(s), g) protection against contamination; CBA a) baseline measurement, b) characteristics for studies using 
second site as control, c) blinded assessment of pirmary outcome(s), d) protection against contamination, e) relieable primary outcome measure(s), f) follow-
up of professionals, g) follow-up of patients; t Baseline characteristic difference, p < 0.05; 
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